A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Abemaciclib
Sponsor: Eli Lilly and Company